You are here: Home // Acne Skin Treatment News // Skin in the Game: How Acne Skin Care Fits GSK’s Drug Portfolio … – Motley Fool

Skin in the Game: How Acne Skin Care Fits GSK’s Drug Portfolio … – Motley Fool

Posted by admin on Aug 05, 2011 | Leave a Comment

Skin in the Game: How Acne Skin Care Fits GSK's Drug Portfolio … Motley Fool By Frank Vinluan, MedCity News | More Articles GlaxoSmithKline (NYSE: GSK ) dermatology and skin subsidiary Stiefel has submitted to regulators a new drug application for tazarotene foam, an acne skin care treatment product. If approved by the US Food … Skin in the Game: How Acne Skin Care Fits GSK's Drug Portfolio …DailyFinance los 3 artículos informativos »

View full post on acne skin treatment: Google Noticias

•  
•  
•  
•  
•  
•  
•  

Technorati Tags: acne, care, Drug, Fits, Fool, Game, GSK's, Motley, Portfolio, skin

Tags: acne, care, Drug, Fits, Fool, Game, GSK's, Motley, Portfolio, skin